Outdoor Workers at High Risk of Skin Cancer

outdoor workers

More than two million outdoor workers are not being provided with any sun protection by their employers, according to the 2017 Skin Health Australia Report Card.

In a national population survey, 45 percent of respondents were required to work outdoors sometimes, regularly or all the time. Fifty-seven percent of these people said their employers did not supply sunscreen, while 66 percent did not supply protective clothing and 80 percent did not supply sunglasses. Continue reading “Outdoor Workers at High Risk of Skin Cancer”

HealthCert Recommends: The IDS 5th World Congress of Dermoscopy

World Congress of Dermoscopy

If you have an interest in dermoscopy and skin cancer medicine, don’t miss the International Dermoscopy Society’s 5th World Congress of Dermoscopy, to be held in Thessaloniki, Greece from 14 to 16 June 2018.

REGISTER NOW

The Congress will bring together passionate dermoscopists from around the globe, from novice researchers to experienced clinicians. It offers a great opportunity for medical professionals interested in skin cancer to learn about the latest research in dermoscopy from inspirational thought leaders in the field. Continue reading “HealthCert Recommends: The IDS 5th World Congress of Dermoscopy”

Do skin cancers on elderly patients always need to be treated?

elderly patients

In very elderly patients, less aggressive skin cancers on the faces might not always need to be treated, according to a study in the US. Research suggests that the age and relative lifespan of the patient should be taken into consideration when deliberating treatment for slow-growing non-melanoma skin cancer on the face.

In a study published in JAMA Surgery, researchers said that there are multiple ways to treat non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, and that the decision to treat them should take into account the patient’s lifestyle, needs and wishes. Researchers also advised that patients need to understand what the course of the cancer usually is. Continue reading “Do skin cancers on elderly patients always need to be treated?”

How does early life sun exposure affect skin cancer risk?

risk

How does sun exposure in early life affect risk of developing basal cell and squamous cell carcinomas?

Sun exposure is the main cause of basal cell and squamous cell carcinomas, although pattern and amount differ by cancer type. Sun sensitivity is the major risk factor.

A study published in the Photochemistry and Photobiology journal investigated the risk factors and residential ambient UV in a population-based sample of Australians. The cohort included 916 basal cell carcinomas, 433 squamous cell carcinomas, and 1,224 controls. Continue reading “How does early life sun exposure affect skin cancer risk?”

Skin Cancer Update with A/Prof Giuseppe Argenziano [January 2018]

Skin Cancer Update

A multi-centre study has explored the prevalence of melanoma on hairy scalps in comparison to bald scalps. Associate Professor Giuseppe Argenziano explains in this skin cancer update video that – while around 76 percent of scalp melanomas are found on people with thinning or no hair – a quarter appear on people with hairy scalps.

Scalp melanoma can be aggressive and has a poorer prognosis compared to melanoma found elsewhere on the body, because scalp melanoma is generally thicker at the time of diagnosis. It also looks different depending on where it is located on the scalp itself, making it trickier to identify. Continue reading “Skin Cancer Update with A/Prof Giuseppe Argenziano [January 2018]”

Cutaneous Lymphomas: New Therapies in Development

cutaneous lymphomas

Modern therapies for cutaneous lymphomas were a topic of discussion at the European Academy of Dermatology and Venereology 2017 Congress, which was held in Geneva in September 2017. Continue reading “Cutaneous Lymphomas: New Therapies in Development”

Suturing Technique for Best Cosmetic Outcomes

suturing

How does suturing technique affect cosmetic outcomes after facial surgery? Recent research published in the Journal of the American Academy of Dermatology sought to compare the cosmetic results of simple interrupted sutures versus running subcuticular sutures in facial surgery.

In a controlled trial, adults receiving dermatologic surgery on the face (for conditions such as skin cancer) were randomised to receive either simple interrupted sutures (73 patients) or running subcuticular sutures (69 patients). Continue reading “Suturing Technique for Best Cosmetic Outcomes”

Do we need pigment to develop melanoma?

melanoma

Do we need pigment to develop melanoma? This question was discussed at the 2017 European Academy of Dermatology and Venereology by Professor David E Fisher, who presented interesting findings in melanoma research.

Research shows that black mice with BRAF mutations that activate the RAS/RAF/MEK/ERK pathway develop multiple nevi. On the other hand, 50 percent of red mice with the same changes develop melanoma without being exposed to UV light. If the red mice are albino, no melanoma appears. Continue reading “Do we need pigment to develop melanoma?”

What is the best protection against sunburn?

sunburn

Sunscreen is more effective than shade at protecting the skin from sunburn, although neither approach alone can completely prevent it, according to recent research.

Researchers in Lake Lewisville, Texas, sought to discover how well shade from a beach umbrella protects against sunburn and how it compares with protection provided by high-SPF sunscreen. Continue reading “What is the best protection against sunburn?”

Skin Cancer Update with A/Prof Giuseppe Argenziano [November]

skin cancer update

In this month’s skin cancer update video, Associate Professor Giuseppe Argenziano discusses which adjuvant therapies are most effective in the treatment of advanced melanoma.

In stage 3 melanoma patients who have their primary tumour surgically excised, five-year recurrence rates are 70 percent in patients who receive no adjuvant therapy; 64 percent in patients who receive Interferon; 59 percent in patients who receive Ipilimumab; 38 percent in patients who receive Nivolumab; and 37 percent in patients who receive a combination of target therapies. Continue reading “Skin Cancer Update with A/Prof Giuseppe Argenziano [November]”